The broader health impacts of GLP-1s are just beginning to be felt, showing incredible promise in improving metabolic health and even treating addiction
What To Expect During the Transition During the first 24 weeks after the switch, individuals may experience temporary changes, including: Mild nausea Fluctuating appetite Altered digestion or fullness cues Slower or faster weight changes These effects generally settle as the body adapts to tirzepatides dual-hormone activity
Novo Nordisk has successfully trialled a daily pill version of Wegovy (oral semaglutide) specifically for weight loss in 25mg and 50mg doses
Ask specific questions Do I need to change how I take my GLP-1 medication before this surgery? Are there special fasting or diet instructions because Im on this drug? Who should manage my blood sugar or weight medication around the time of surgery? Do not stop the medication on your own: For some patients, especially those with diabetes, abruptly stopping can cause poor glucose control or other issues
This dual effect helps regulate blood glucose levels without causing significant hypoglycemia, as the insulin response diminishes when blood sugar normalizes
